|
Harnessing novel immune escape mechanisms for cancer therapeutics: OXAB1 target validation, proof of concept and preclinical development. |
| |
|
Employment - Oxford BioTherapeutics |
Patents, Royalties, Other Intellectual Property - Oxford BioTherapeutics |
Travel, Accommodations, Expenses - Oxford BioTherapeutics |
| |
|
Employment - Oxford BioTherapeutics |
| |
|
Employment - Oxford BioTherapeutics |
| |
|
Employment - Oxford BioTherapeutics |
| |
|
Employment - Oxford BioTherapeutics |
| |
|
Employment - Oxford BioTherapeutics |
| |
|
Employment - Oxford BioTherapeutics |
| |
|
Employment - Oxford BioTherapeutics |
| |
|
Employment - Oxford BioTherapeutics |
| |
|
Employment - Oxford BioTherapeutics |
| |
|
Employment - Oxford BioTherapeutics |
| |
|
Employment - Oxford BioTherapeutics |
| |
|
Employment - Oxford BioTherapeutics |
| |
|
Employment - Oxford BioTherapeutics |
| |
|
No Relationships to Disclose |
| |
|
Employment - Oxford BioTherapeutics |